Chase AIPricingFAQs
Display currency
Loading news…

Arresto BioSciences

ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).
Palo Alto, California, United States Founded 2007 11-50 employees For Profit

Arresto Biosciences, Inc., a biotechnology company, develops medicines to treat cancer and fibrotic diseases by targeting molecules from

Arresto BioSciences was acquired by Gilead Sciences in 2010.
Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
2
Patents
4

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
20
Active products
7
Patents granted
4
Trademarks
0
Top patent class
Medical Or Veterinary Science; Hygiene

Company Info

Founded
2007
Employees
11-50
Operating status
Closed
Company type
For Profit
Org types
company
HQ
Palo Alto, California, United States
Region
San Francisco Bay Area, Silicon Valley, West Coast
Exit date
Dec 20, 2010

Signals & Scores

Heat score
Medium
Trend (7d)
4.4
Trend (30d)
7.7
Trend (90d)
8.6

Key People at Arresto BioSciences

President and CEO
2
professional contacts at Arresto BioSciences
Contact execs at Arresto BioSciences

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Arresto BioSciences

Loading news…

FAQs about Arresto BioSciences

People who checked this page also checked these

Browse the full Acquirezy directory.
Arresto BioSciences - Company Profile, Full Acquisitions List, Funding and Investments